Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Parkinson’s Disease Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Parkinson’s Disease Therapeuticsmarket, defines the market attractiveness level of Parkinson’s Disease Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Parkinson’s Disease Therapeutics industry, describes the types of Parkinson’s Disease Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Parkinson’s Disease Therapeutics market and the development prospects and opportunities of Parkinson’s Disease Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Parkinson’s Disease Therapeutics market in Chapter 13.
By Player:
Impax Labs
Orion Corporation
GlaxoSmithKline
H Lundbeck A/S
Teva Pharmaceutical Industries Ltd
Newron Pharmaceuticals SpA
F Hoffman-La Roche
UCB SA
Biogen
Boehringer Ingelheim GmbH
Novartis AG
Abbvie
By Type:
Oral
Transdermal
Subcutaneous
Intestinal Infusion
By End-User:
Hospitals
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Parkinson’s Disease Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Parkinson’s Disease Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Parkinson’s Disease Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Parkinson’s Disease Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Parkinson’s Disease Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Parkinson’s Disease Therapeutics Consumption (2017-2022)
-
7.2 United States Parkinson’s Disease Therapeutics Consumption (2017-2022)
-
7.3 Europe Parkinson’s Disease Therapeutics Consumption (2017-2022)
-
7.4 China Parkinson’s Disease Therapeutics Consumption (2017-2022)
-
7.5 Japan Parkinson’s Disease Therapeutics Consumption (2017-2022)
-
7.6 India Parkinson’s Disease Therapeutics Consumption (2017-2022)
-
7.7 South Korea Parkinson’s Disease Therapeutics Consumption (2017-2022)
8 Region and Country-wise Parkinson’s Disease Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Parkinson’s Disease Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Parkinson’s Disease Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Parkinson’s Disease Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Parkinson’s Disease Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Parkinson’s Disease Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Parkinson’s Disease Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Parkinson’s Disease Therapeutics Consumption Forecast (2022-2028)
9 Global Parkinson’s Disease Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Parkinson’s Disease Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Transdermal Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Subcutaneous Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Intestinal Infusion Consumption and Growth Rate (2017-2022)
-
9.2 Global Parkinson’s Disease Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Parkinson’s Disease Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Parkinson’s Disease Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Transdermal Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Subcutaneous Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Intestinal Infusion Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Parkinson’s Disease Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Parkinson’s Disease Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Parkinson’s Disease Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Parkinson’s Disease Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Parkinson’s Disease Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Parkinson’s Disease Therapeutics Market Competitive Analysis
-
14.1 Impax Labs
-
14.1.1 Impax Labs Company Details
-
14.1.2 Impax Labs Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Impax Labs Parkinson’s Disease Therapeutics Product and Service
-
14.2 Orion Corporation
-
14.2.1 Orion Corporation Company Details
-
14.2.2 Orion Corporation Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Orion Corporation Parkinson’s Disease Therapeutics Product and Service
-
14.3 GlaxoSmithKline
-
14.3.1 GlaxoSmithKline Company Details
-
14.3.2 GlaxoSmithKline Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Product and Service
-
14.4 H Lundbeck A/S
-
14.4.1 H Lundbeck A/S Company Details
-
14.4.2 H Lundbeck A/S Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 H Lundbeck A/S Parkinson’s Disease Therapeutics Product and Service
-
14.5 Teva Pharmaceutical Industries Ltd
-
14.5.1 Teva Pharmaceutical Industries Ltd Company Details
-
14.5.2 Teva Pharmaceutical Industries Ltd Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Teva Pharmaceutical Industries Ltd Parkinson’s Disease Therapeutics Product and Service
-
14.6 Newron Pharmaceuticals SpA
-
14.6.1 Newron Pharmaceuticals SpA Company Details
-
14.6.2 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product and Service
-
14.7 F Hoffman-La Roche
-
14.7.1 F Hoffman-La Roche Company Details
-
14.7.2 F Hoffman-La Roche Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 F Hoffman-La Roche Parkinson’s Disease Therapeutics Product and Service
-
14.8 UCB SA
-
14.8.1 UCB SA Company Details
-
14.8.2 UCB SA Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 UCB SA Parkinson’s Disease Therapeutics Product and Service
-
14.9 Biogen
-
14.9.1 Biogen Company Details
-
14.9.2 Biogen Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Biogen Parkinson’s Disease Therapeutics Product and Service
-
14.10 Boehringer Ingelheim GmbH
-
14.10.1 Boehringer Ingelheim GmbH Company Details
-
14.10.2 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product and Service
-
14.11 Novartis AG
-
14.11.1 Novartis AG Company Details
-
14.11.2 Novartis AG Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Novartis AG Parkinson’s Disease Therapeutics Product and Service
-
14.12 Abbvie
-
14.12.1 Abbvie Company Details
-
14.12.2 Abbvie Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Abbvie Parkinson’s Disease Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Parkinson’s Disease Therapeutics
-
Figure Parkinson’s Disease Therapeutics Picture
-
Table Global Parkinson’s Disease Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Parkinson’s Disease Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Parkinson’s Disease Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Parkinson’s Disease Therapeutics Consumption by Country (2017-2022)
-
Figure United States Parkinson’s Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Parkinson’s Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Parkinson’s Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Parkinson’s Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Parkinson’s Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Parkinson’s Disease Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Parkinson’s Disease Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Parkinson’s Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Parkinson’s Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Parkinson’s Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Parkinson’s Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Parkinson’s Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Parkinson’s Disease Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Transdermal Consumption and Growth Rate (2017-2022)
-
Figure Global Subcutaneous Consumption and Growth Rate (2017-2022)
-
Figure Global Intestinal Infusion Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Transdermal Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Subcutaneous Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intestinal Infusion Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Parkinson’s Disease Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Parkinson’s Disease Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Impax Labs (Foundation Year, Company Profile and etc.)
-
Table Impax Labs Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Impax Labs Parkinson’s Disease Therapeutics Product and Service
-
Table Orion Corporation (Foundation Year, Company Profile and etc.)
-
Table Orion Corporation Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Orion Corporation Parkinson’s Disease Therapeutics Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Parkinson’s Disease Therapeutics Product and Service
-
Table H Lundbeck A/S (Foundation Year, Company Profile and etc.)
-
Table H Lundbeck A/S Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table H Lundbeck A/S Parkinson’s Disease Therapeutics Product and Service
-
Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Ltd Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Ltd Parkinson’s Disease Therapeutics Product and Service
-
Table Newron Pharmaceuticals SpA (Foundation Year, Company Profile and etc.)
-
Table Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product and Service
-
Table F Hoffman-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffman-La Roche Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffman-La Roche Parkinson’s Disease Therapeutics Product and Service
-
Table UCB SA (Foundation Year, Company Profile and etc.)
-
Table UCB SA Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB SA Parkinson’s Disease Therapeutics Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Parkinson’s Disease Therapeutics Product and Service
-
Table Boehringer Ingelheim GmbH (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Parkinson’s Disease Therapeutics Product and Service
-
Table Abbvie (Foundation Year, Company Profile and etc.)
-
Table Abbvie Parkinson’s Disease Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbvie Parkinson’s Disease Therapeutics Product and Service
-
